動脈瘤コイリング・塞栓装置市場：製品タイプ、用途別-2025-2030年の世界予測

動脈瘤コイリング・塞栓装置市場は、2023年に2億9,190万米ドルと評価され、2024年には3億2,208万米ドルに達すると予測され、CAGR 10.43%で成長し、2030年には5億8,464万米ドルに達すると予測されています。

動脈瘤コイリング・塞栓装置市場には、動脈瘤、特に脳動脈瘤の低侵襲治療に使用される医療機器が含まれます。これらの医療機器は、動脈瘤への血流を遮断し、血液凝固を促進して血管壁を補強するコイルと塞栓剤で構成されます。その必要性は、動脈瘤の有病率の増加と、患者の回復を促進し入院期間を短縮する侵襲の少ない治療法へのシフトから生じています。主な用途は、血管内コイリング手技を中心とした病院や神経クリニックなどです。市場成長の原動力は、神経画像技術の進歩、心血管および神経血管疾患の世界の発生率の増加、早期診断につながる意識の高まりです。新興市場には、ヘルスケアのインフラが整備され、先進医療機器の導入が進んでいるため、ビジネスチャンスが眠っています。費用対効果が高く、耐久性に優れ、洗練された医療機器を開発し、さまざまな患者のニーズに対応することが、市場の潜在力を獲得することにつながります。主な市場阻害要因としては、特に新興経済諸国において、高い医療費、厳しい規制状況、償還に関する課題などが挙げられます。変化する規制への適応と高い参入障壁の克服は依然として課題です。この市場では、放射線不透過性のハイドロゲルをベースとしたコイルや、優れた治療効果をもたらす生体活性コイルなど、最先端のイノベーションが求められています。企業は、装置の生体適合性と有効性を高めるために、研究提携と開発に投資することが推奨されます。精密なコイリングのための人工知能の統合は、精密な画像誘導介入を提供する有望な技術革新分野です。個別化医療に向けた戦略的アプローチの再編成と手技効率の向上は競争優位性をもたらします。デジタルヘルスプラットフォームと遠隔医療を活用し、患者管理システムを強化し、ヘルスケアプロバイダーとの強力な協力関係を育むことに成長の展望があります。最終的には、製品ポートフォリオを最適化し、費用対効果に取り組み、技術的進歩を活用することで、イノベーション主導のソリューションにますます傾きつつある進化する状況において、プレーヤーの市場ポジションは確固たるものになると思われます。

市場力学：急速に進化する動脈瘤コイリング・塞栓装置市場の主要市場インサイトを公開

動脈瘤コイリング・塞栓装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 未破裂頭蓋内動脈瘤（UIA）の検出ニーズの高まり
  • 出血や血管異常の発生率の増加
  • 脳動脈瘤およびその他の神経疾患に対する取り組みと意識向上
• 市場抑制要因
  • 動脈瘤コイリング・塞栓装置に関連する高コスト
• 市場機会
  • 動脈瘤コイリング・塞栓装置における新たな技術進歩
  • 動脈瘤の新規治療法を開発するための活発な研究活動
• 市場の課題
  • 動脈瘤コイリング・塞栓装置に対する厳しい規制プロトコル

ポーターの5つの力：動脈瘤コイリング・塞栓装置市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動脈瘤コイリング・塞栓装置市場における外部からの影響の把握

外部マクロ環境要因は、動脈瘤コイリング・塞栓装置市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動脈瘤コイリング・塞栓装置市場における競合情勢の把握

動脈瘤コイリング・塞栓装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動脈瘤コイリング・塞栓装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動脈瘤コイリング・塞栓装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動脈瘤コイリング・塞栓装置市場における成功への道筋を描く

動脈瘤コイリング・塞栓装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 未破裂頭蓋内動脈瘤（UIA）の検出の必要性が高まっている
    • 血管の出血や異常の発生率増加
    • 脳動脈瘤やその他の神経疾患に関する取り組みと啓発
  • 抑制要因
    • 動脈瘤コイリング・塞栓装置に関連する高コスト
  • 機会
    • 動脈瘤コイリング・塞栓装置における新たな技術進歩
    • 動脈瘤の新しい治療法を開発するための強力な調査活動
  • 課題
    • 動脈瘤コイリング・塞栓装置の厳格な規制プロトコル
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動脈瘤コイリング・塞栓装置市場：製品タイプ別

• アクセス配信デバイス
• 動脈瘤クリップ
• バルーンおよびステント補助コイル
• 塞栓コイル
• 流れ転換装置
• 液体塞栓剤

第7章 動脈瘤コイリング・塞栓装置市場：用途別

• 外来手術ユニット
• クリニック
• 病院

第8章 南北アメリカの動脈瘤コイリング・塞栓装置市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の動脈瘤コイリング・塞栓装置市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの動脈瘤コイリング・塞栓装置市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acandis GmbH
• Artio Medical, Inc.
• ASAHI INTECC CO.,LTD.
• B. Braun Melsungen AG
• BALT group
• Boston Scientific Corporation
• Braile Biomedica
• Cook Group Incorporated
• Johnson & Johnson Services, Inc.
• Kaneka Corporation
• Lepu Medical Technology（Beijing）Co.,Ltd.
• Medtronic PLC
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Perflow Medical Ltd.
• phenox GmbH
• Rapid Medical Ltd.
• Shape Memory Medical Inc.
• Spartan Micro, Inc.
• Stryker Corporation
• Terumo Group
• Wallaby Medical, Inc.

LIST OF FIGURES

• FIGURE 1. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY ACCESS DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY BALLOON & STENT-ASSISTED COILS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY LIQUID EMBOLIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL UNITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CHINA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ITALY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. POLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. QATAR ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. ANEURYSM COILING & EMBOLIZATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Aneurysm Coiling & Embolization Devices Market was valued at USD 291.90 million in 2023, expected to reach USD 322.08 million in 2024, and is projected to grow at a CAGR of 10.43%, to USD 584.64 million by 2030.

The Aneurysm Coiling & Embolization Devices market encompasses medical devices used in the minimally invasive treatment of aneurysms, particularly cerebral aneurysms. These devices comprise coils and embolization agents that block blood flow to the aneurysm, promoting clotting and reinforcing the vessel wall. Their necessity arises from the increasing prevalence of aneurysms coupled with a shift towards less invasive procedures that enhance patient recovery and reduce hospitalization. The primary applications include hospitals and neurological clinics, focusing on endovascular coiling procedures. Market growth is driven by advances in neuroimaging technologies, increasing global incidence of cardiovascular and neurovascular conditions, and heightened awareness leading to early diagnosis. Opportunities lie in emerging markets due to improved healthcare infrastructure and increasing adoption of advanced medical devices. Innovating cost-effective, durable, and sophisticated devices to cater to varying patient needs will help players capture market potential. Major market restraining factors include high procedural costs, stringent regulatory landscapes, and reimbursement challenges, especially in developing economies. Adaptation to changing regulations and overcoming high entry barriers remain challenging. The market calls for cutting-edge innovations such as radiopaque hydrogel-based coils and bioactive coils offering superior outcomes. Companies are advised to invest in research partnerships and development to enhance device biocompatibility and effectiveness. Artificial Intelligence integration for precise coiling is a promising innovation arena, offering precise image-guided interventions. Realigning strategic approaches towards personalized medicine and enhancement in procedural efficiency can offer competitive advantages. Growth prospects lie in leveraging digital health platforms and telemedicine, enhancing patient management systems and fostering strong collaborations with healthcare providers. Ultimately, optimizing product portfolios, addressing cost-effectiveness, and capitalizing on technological advancements will solidify players' market positions in an evolving landscape that is increasingly leaning towards innovation-driven solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aneurysm Coiling & Embolization Devices Market

The Aneurysm Coiling & Embolization Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for detection of unruptured intracranial aneurysms (UIAs)
  • Growing incidence of hemorrhages and abnormalities in blood vessels
  • Initiatives and awareness for brain aneurysm and other neurological disorders
• Market Restraints
  • High costs associated with aneurysm coiling & embolization devices
• Market Opportunities
  • Emerging technological advancements in aneurysm coiling & embolization devices
  • Robust research activities to develop novel treatments for aneurysms
• Market Challenges
  • Stringent regulatory protocols for aneurysm coiling & embolization devices

Porter's Five Forces: A Strategic Tool for Navigating the Aneurysm Coiling & Embolization Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aneurysm Coiling & Embolization Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aneurysm Coiling & Embolization Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aneurysm Coiling & Embolization Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aneurysm Coiling & Embolization Devices Market

A detailed market share analysis in the Aneurysm Coiling & Embolization Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aneurysm Coiling & Embolization Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aneurysm Coiling & Embolization Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aneurysm Coiling & Embolization Devices Market

A strategic analysis of the Aneurysm Coiling & Embolization Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aneurysm Coiling & Embolization Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, Artio Medical, Inc., ASAHI INTECC CO.,LTD., B. Braun Melsungen AG, BALT group, Boston Scientific Corporation, Braile Biomedica, Cook Group Incorporated, Johnson & Johnson Services, Inc., Kaneka Corporation, Lepu Medical Technology(Beijing)Co.,Ltd., Medtronic PLC, MicroPort Scientific Corporation, Penumbra, Inc., Perflow Medical Ltd., phenox GmbH, Rapid Medical Ltd., Shape Memory Medical Inc., Spartan Micro, Inc., Stryker Corporation, Terumo Group, and Wallaby Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the Aneurysm Coiling & Embolization Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Access Delivery Devices, Aneurysm Clips, Balloon & Stent-Assisted Coils, Embolization Coils, Flow Diversion Devices, and Liquid Embolic Agents.
• Based on Application, market is studied across Ambulatory Surgical Units, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for detection of unruptured intracranial aneurysms (UIAs)
    • 5.1.1.2. Growing incidence of hemorrhages and abnormalities in blood vessels
    • 5.1.1.3. Initiatives and awareness for brain aneurysm and other neurological disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with aneurysm coiling & embolization devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging technological advancements in aneurysm coiling & embolization devices
    • 5.1.3.2. Robust research activities to develop novel treatments for aneurysms
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory protocols for aneurysm coiling & embolization devices
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aneurysm Coiling & Embolization Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Access Delivery Devices
• 6.3. Aneurysm Clips
• 6.4. Balloon & Stent-Assisted Coils
• 6.5. Embolization Coils
• 6.6. Flow Diversion Devices
• 6.7. Liquid Embolic Agents

7. Aneurysm Coiling & Embolization Devices Market, by Application

• 7.1. Introduction
• 7.2. Ambulatory Surgical Units
• 7.3. Clinics
• 7.4. Hospitals

8. Americas Aneurysm Coiling & Embolization Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Aneurysm Coiling & Embolization Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Aneurysm Coiling & Embolization Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acandis GmbH
• 2. Artio Medical, Inc.
• 3. ASAHI INTECC CO.,LTD.
• 4. B. Braun Melsungen AG
• 5. BALT group
• 6. Boston Scientific Corporation
• 7. Braile Biomedica
• 8. Cook Group Incorporated
• 9. Johnson & Johnson Services, Inc.
• 10. Kaneka Corporation
• 11. Lepu Medical Technology(Beijing)Co.,Ltd.
• 12. Medtronic PLC
• 13. MicroPort Scientific Corporation
• 14. Penumbra, Inc.
• 15. Perflow Medical Ltd.
• 16. phenox GmbH
• 17. Rapid Medical Ltd.
• 18. Shape Memory Medical Inc.
• 19. Spartan Micro, Inc.
• 20. Stryker Corporation
• 21. Terumo Group
• 22. Wallaby Medical, Inc.